Financial

Veteran Cardiology Medtech Executive Tim O’Malley Joins iMedrix Mobile Cardiology as CEO

KardioScreen-Intelligent Medical Metrics in Cardiology allowing for medical grade diagnostics while in a Mobile environment MILPITAS, Calif., Jan. 29, 2021 /PRNewswire/ — Tim O’Malley, has joined iMedrix Inc. manufacturer of KardioScreen, the world’s first medical-grade mobile cardiac monitoring device, as its new Chief Executive Officer.  Mr. O’Malley joins the firm from EarlySense Inc., where he was […]

Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical

ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has promoted Anna Lucsok to Chief Operating Officer (COO) of Zynex Medical, its pain management division. Joseph Papandrea previously held […]

Spectrum Dynamics Medical Lawsuit Against GE Allowed to Continue; Jury Trial May Proceed

Judge denies both attempts by GE requesting dismissal of technology misappropriation lawsuit filed by Spectrum Dynamics regarding its VERITON® digital scanner unique technology SARASOTA, Fla., Jan. 29, 2021 /PRNewswire/ — Spectrum Dynamics Medical, a global leader, developer, manufacturer and seller of digital SPECT imaging equipment, announced that its lawsuit against GE for trade secret […]

JanOne Prices $6.0 Million Common Stock Offering

LAS VEGAS, Jan. 29, 2021 /PRNewswire/ — JanOne Inc. (NASDAQ: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 571,428 shares of its common stock at a […]

Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its pipeline of late-stage product candidates, and an activity report for the second quarter ended December 31, 2020. Mesoblast Chief Executive Dr Silviu Itescu […]

Edwards Lifesciences Reports Fourth Quarter Results

IRVINE, Calif., Jan. 27, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2020. Fourth Quarter Highlights and Outlook Q4 sales increased 1 percent to $1.2 billion; underlying1 sales flat Q4 TAVR sales grew 2 percent; underlying sales flat Q4 EPS was $0.49; adjusted1 EPS grew 2 percent to $0.50 December […]

BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap Showcase

Westport, CT, Jan. 27, 2021 (GLOBE NEWSWIRE) — Company to provide corporate overview and progress on the rollout of the PURE EP™ System BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]

Cardiovascular Systems, Inc. Announces Sachin H. Jain, MD, MBA, Joins Board of Directors

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Sachin H. Jain, MD, MBA. Dr. Jain is currently President and Chief Executive Officer […]

Abiomed Announces Q3 FY 2021 Record Revenue of $232 Million, up 5% Year Over Year, With 31% Operating Margin

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported record revenue in the third quarter fiscal 2021 of $231.7 million, a year over year increase of 5% compared to Q3 fiscal year 2020 despite the negative impact of COVID-19. Operating income was $71.4 […]